InvestSMART

Immutep Limited (ASX: IMM) - Announcements

- Current share price for IMM : $0.023

ASX company news and announcements for Immutep Limited (IMM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immutep Limited (IMM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immutep Limited (IMM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immutep Limited (IMM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$34 Immutep doses First Patient in TACTI-002 Phase II Trial 6 Mar 2019 6:00PM $0.035 $0.023 fallen by 34.29%
$34 TACTI-mel data presented at World Immunotherapy Congress 6 Mar 2019 8:20AM $0.034 $0.023 fallen by 32.35%
$34 Immutep to present at Oppenheimer Healthcare Conference 4 Mar 2019 6:59PM $0.032 $0.023 fallen by 28.13%
$34 Half Year Accounts 27 Feb 2019 4:58PM $0.030 $0.023 fallen by 23.33%
$34 Immutep to present at upcoming industry conferences 26 Feb 2019 1:29PM $0.030 $0.023 fallen by 23.33%
$34 Immutep Presentation to Emergence Conference 25 Feb 2019 8:18AM $0.030 $0.023 fallen by 23.33%
$34 Immutep Investor Update 31 Jan 2019 11:01AM $0.029 $0.023 fallen by 20.69%
$34 Appendix 4C - quarterly 24 Jan 2019 4:14PM $0.030 $0.023 fallen by 23.33%
$34 Immutep enters into collaboration with CYTLIMIC 7 Jan 2019 8:22AM $0.031 $0.023 fallen by 25.81%
$34 Change of Director's Interest Notice - Dr Howard 4 Jan 2019 6:32PM $0.031 $0.023 fallen by 25.81%
$34 Change of Director's Interest Notice - Mr Voigt 4 Jan 2019 6:17PM $0.031 $0.023 fallen by 25.81%
$34 Appendix 3B 2 Jan 2019 6:12PM $0.028 $0.023 fallen by 17.86%
$34 Becoming a substantial holder 24 Dec 2018 8:24AM $0.028 $0.023 fallen by 17.86%
$34 Disclosure Under LR 3.10.5A and 7.1A.4(b) 21 Dec 2018 9:53AM $0.029 $0.023 fallen by 20.69%
$34 Cleansing Notice 21 Dec 2018 9:52AM $0.029 $0.023 fallen by 20.69%
$34 Appendix 3B 21 Dec 2018 9:51AM $0.029 $0.023 fallen by 20.69%
$34 Cleansing prospectus for issue of warrants 20 Dec 2018 9:14AM $0.032 $0.023 fallen by 28.13%
$34 Immutep announces US$5.2 million capital raising 19 Dec 2018 4:10PM $0.032 $0.023 fallen by 28.13%
$34 European patent granted for IMP321 & antibody combinations 29 Nov 2018 8:21AM $0.036 $0.023 fallen by 36.11%
$34 Immutep granted European patent for IMP321 28 Nov 2018 8:25AM $0.038 $0.023 fallen by 39.47%
$34 Immutep presents new TACTI-mel data at ICI Europe Summit 27 Nov 2018 4:13PM $0.038 $0.023 fallen by 39.47%
$34 Change of Director's Interest Notice - Dr Howard 26 Nov 2018 6:01PM $0.040 $0.023 fallen by 42.50%
$34 Appendix 3B 21 Nov 2018 4:20PM $0.037 $0.023 fallen by 37.84%
$34 Results of Meeting 16 Nov 2018 12:39PM $0.039 $0.023 fallen by 41.03%
$34 2018 AGM CEO Presentation 16 Nov 2018 8:23AM $0.037 $0.023 fallen by 37.84%

701 - 725 of 791 results

Page 29 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.